ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/03/23 | 3,370 | 3,415 | 3,345 | 3,360 | +5 | +0.1% | 500,700 |
| 2021/03/22 | 3,410 | 3,440 | 3,320 | 3,355 | -20 | -0.6% | 531,700 |
| 2021/03/19 | 3,400 | 3,455 | 3,370 | 3,375 | +40 | +1.2% | 919,500 |
| 2021/03/18 | 3,370 | 3,390 | 3,310 | 3,335 | -20 | -0.6% | 590,600 |
| 2021/03/17 | 3,275 | 3,390 | 3,270 | 3,355 | +100 | +3.1% | 664,500 |
| 2021/03/16 | 3,300 | 3,335 | 3,230 | 3,255 | -100 | -3% | 819,800 |
| 2021/03/15 | 3,330 | 3,370 | 3,285 | 3,355 | -25 | -0.7% | 704,600 |
| 2021/03/12 | 3,370 | 3,425 | 3,305 | 3,380 | -55 | -1.6% | 947,400 |
| 2021/03/11 | 3,465 | 3,485 | 3,380 | 3,435 | -90 | -2.6% | 917,700 |
| 2021/03/10 | 3,495 | 3,610 | 3,475 | 3,525 | +35 | +1% | 889,000 |
| 2021/03/09 | 3,545 | 3,565 | 3,430 | 3,490 | -125 | -3.5% | 1,669,900 |
| 2021/03/08 | 3,690 | 3,705 | 3,585 | 3,615 | -105 | -2.8% | 1,021,100 |
| 2021/03/05 | 3,760 | 3,790 | 3,630 | 3,720 | +50 | +1.4% | 1,171,000 |
| 2021/03/04 | 3,605 | 3,690 | 3,530 | 3,670 | +10 | +0.3% | 898,700 |
| 2021/03/03 | 3,675 | 3,720 | 3,605 | 3,660 | -20 | -0.5% | 820,000 |
| 2021/03/02 | 3,625 | 3,735 | 3,570 | 3,680 | +125 | +3.5% | 1,197,600 |
| 2021/03/01 | 3,575 | 3,630 | 3,505 | 3,555 | -25 | -0.7% | 750,300 |
| 2021/02/26 | 3,495 | 3,650 | 3,430 | 3,580 | +60 | +1.7% | 1,885,500 |
| 2021/02/25 | 3,365 | 3,520 | 3,330 | 3,520 | +220 | +6.7% | 1,661,800 |
| 2021/02/24 | 3,235 | 3,300 | 3,195 | 3,300 | +30 | +0.9% | 709,100 |
| 2021/02/22 | 3,230 | 3,275 | 3,190 | 3,270 | +75 | +2.3% | 621,200 |
| 2021/02/19 | 3,175 | 3,240 | 3,155 | 3,195 | -35 | -1.1% | 390,000 |
| 2021/02/18 | 3,220 | 3,385 | 3,195 | 3,230 | +40 | +1.3% | 1,309,000 |
| 2021/02/17 | 3,205 | 3,250 | 3,185 | 3,190 | +15 | +0.5% | 573,700 |
| 2021/02/16 | 3,160 | 3,185 | 3,100 | 3,175 | +5 | +0.2% | 586,000 |
| 2021/02/15 | 3,200 | 3,200 | 3,140 | 3,170 | -10 | -0.3% | 385,500 |
| 2021/02/12 | 3,200 | 3,230 | 3,160 | 3,180 | +55 | +1.8% | 673,700 |
| 2021/02/10 | 3,050 | 3,145 | 3,035 | 3,125 | +20 | +0.6% | 396,300 |
| 2021/02/09 | 3,105 | 3,130 | 3,010 | 3,105 | -70 | -2.2% | 950,400 |
| 2021/02/08 | 3,200 | 3,215 | 3,140 | 3,175 | +45 | +1.4% | 862,300 |
| 2021/02/05 | 3,050 | 3,160 | 3,045 | 3,130 | +50 | +1.6% | 832,400 |
| 2021/02/04 | 3,110 | 3,115 | 3,010 | 3,080 | -90 | -2.8% | 1,494,900 |
| 2021/02/03 | 3,205 | 3,255 | 3,155 | 3,170 | -80 | -2.5% | 1,269,100 |
| 2021/02/02 | 3,250 | 3,250 | 3,100 | 3,250 | +40 | +1.2% | 2,285,300 |
| 2021/02/01 | 3,390 | 3,390 | 3,110 | 3,210 | -240 | -7% | 4,535,100 |
| 2021/01/29 | 3,325 | 3,800 | 3,325 | 3,450 | +335 | +10.8% | 15,250,100 |
| 2021/01/28 | 2,936 | 3,210 | 2,867 | 3,115 | +373 | +13.6% | 7,019,800 |
| 2021/01/27 | 2,746 | 2,789 | 2,633 | 2,742 | +246 | +9.9% | 3,121,600 |
| 2021/01/26 | 2,475 | 2,586 | 2,421 | 2,496 | +13 | +0.5% | 1,276,400 |
| 2021/01/25 | 2,452 | 2,486 | 2,438 | 2,483 | +22 | +0.9% | 366,900 |
| 2021/01/22 | 2,380 | 2,461 | 2,366 | 2,461 | +87 | +3.7% | 415,500 |
| 2021/01/21 | 2,387 | 2,392 | 2,364 | 2,374 | -14 | -0.6% | 340,200 |
| 2021/01/20 | 2,400 | 2,402 | 2,356 | 2,388 | -44 | -1.8% | 377,400 |
| 2021/01/19 | 2,512 | 2,512 | 2,427 | 2,432 | -79 | -3.1% | 341,200 |
| 2021/01/18 | 2,501 | 2,514 | 2,488 | 2,511 | -4 | -0.2% | 140,200 |
| 2021/01/15 | 2,504 | 2,520 | 2,486 | 2,515 | +6 | +0.2% | 289,700 |
| 2021/01/14 | 2,478 | 2,523 | 2,465 | 2,509 | +34 | +1.4% | 389,500 |
| 2021/01/13 | 2,495 | 2,497 | 2,456 | 2,475 | -59 | -2.3% | 399,600 |
| 2021/01/12 | 2,537 | 2,572 | 2,526 | 2,534 | +24 | +1% | 478,900 |
| 2021/01/08 | 2,499 | 2,530 | 2,475 | 2,510 | +43 | +1.7% | 356,100 |
901～
950
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
